La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Frequency Therapeutics Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
David Lucchino
Amministratore delegato
US$3.2m
Compenso totale
Percentuale dello stipendio del CEO | 19.9% |
Mandato del CEO | 9yrs |
Proprietà del CEO | 1.7% |
Durata media del management | Nessun dato |
Durata media del Consiglio di amministrazione | 7.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Is Frequency Therapeutics (NASDAQ:FREQ) Weighed On By Its Debt Load?
Jan 01Frequency Therapeutics (NASDAQ:FREQ) Has Debt But No Earnings; Should You Worry?
Jan 19Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are Reducing Their Forecasts For This Year
Aug 18Health Check: How Prudently Does Frequency Therapeutics (NASDAQ:FREQ) Use Debt?
Jul 31Frequency Therapeutics (FREQ) Investor Presentation - Slideshow
Jun 18Frequency Therapeutics: A Look At What's Next After A Disappointing Data Readout
Apr 21Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are More Bearish Than They Used To Be
Apr 04We're Not Worried About Frequency Therapeutics' (NASDAQ:FREQ) Cash Burn
Mar 15If You Had Bought Frequency Therapeutics (NASDAQ:FREQ) Shares A Year Ago You'd Have Earned 55% Returns
Jan 22Have Insiders Sold Frequency Therapeutics, Inc. (NASDAQ:FREQ) Shares Recently?
Dec 27Frequency Therapeutics to host investor event in early January next year
Dec 18How Much Are Frequency Therapeutics, Inc. (NASDAQ:FREQ) Insiders Taking Off The Table?
Dec 10Frequency Therapeutics, Inc. (NASDAQ:FREQ) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 19Frequency Therapeutics EPS beats by $0.16, beats on revenue
Nov 16Frequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 Results
Nov 09Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$59m |
Jun 30 2023 | n/a | n/a | -US$67m |
Mar 31 2023 | n/a | n/a | -US$78m |
Dec 31 2022 | US$3m | US$630k | -US$82m |
Sep 30 2022 | n/a | n/a | -US$86m |
Jun 30 2022 | n/a | n/a | -US$91m |
Mar 31 2022 | n/a | n/a | -US$88m |
Dec 31 2021 | US$6m | US$600k | -US$85m |
Sep 30 2021 | n/a | n/a | -US$73m |
Jun 30 2021 | n/a | n/a | -US$54m |
Mar 31 2021 | n/a | n/a | -US$42m |
Dec 31 2020 | US$5m | US$551k | -US$27m |
Sep 30 2020 | n/a | n/a | -US$22m |
Jun 30 2020 | n/a | n/a | -US$18m |
Mar 31 2020 | n/a | n/a | -US$19m |
Dec 31 2019 | US$7m | US$442k | -US$20m |
Sep 30 2019 | n/a | n/a | -US$20m |
Jun 30 2019 | n/a | n/a | -US$23m |
Mar 31 2019 | n/a | n/a | -US$21m |
Dec 31 2018 | US$744k | US$367k | -US$19m |
Compensazione vs Mercato: La retribuzione totale di David ($USD 3.16M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 2.44M ).
Compensazione vs guadagni: La retribuzione di David è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
David Lucchino (53 yo)
9yrs
Mandato
US$3,159,278
Compensazione
Mr. David L. Lucchino is a Co-Founder of Frequency Therapeutics, Inc. and has been its Chief Executive Officer and President since November 2014. Mr. Lucchino served as Treasurer and Secretary of Frequency...
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | 9yrs | US$3.16m | 1.73% $ 9.5m | |
Senior Advisor & Member of PCA Regenerative Medicine Advisory Board | 6.7yrs | Nessun dato | Nessun dato | |
Independent Vice Chairman | 7.2yrs | US$104.32k | 0.22% $ 1.2m | |
Independent Director & Member of PCA Regenerative Medicine Advisory Board | 7.2yrs | US$133.32k | 0.66% $ 3.6m | |
Independent Director | 3.2yrs | US$92.82k | 0% $ 0 | |
Member of PCA Regenerative Medicine Advisory Board | no data | Nessun dato | Nessun dato | |
Member of PCA Regenerative Medicine Advisory Board | no data | Nessun dato | Nessun dato | |
Member of PCA Regenerative Medicine Advisory Board | no data | Nessun dato | Nessun dato | |
Member of PCA Regenerative Medicine Advisory Board | no data | Nessun dato | Nessun dato | |
Member of PCA Regenerative Medicine Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Clinical Advisory Board | no data | Nessun dato | Nessun dato |
7.2yrs
Durata media
72.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di FREQ sono considerati esperti (durata media dell'incarico 7.2 anni).